The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2015

Filed:

Apr. 11, 2014
Applicants:

Lloyd H. Kasper, Norwhich, VT (US);

Jacqueline Y. Smith, Lebanon, NH (US);

Inventors:

Lloyd H. Kasper, Norwhich, VT (US);

Jacqueline Y. Smith, Lebanon, NH (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); A61K 38/07 (2006.01); C07K 14/52 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6863 (2013.01); A61K 38/07 (2013.01); C07K 14/52 (2013.01); G01N 2800/285 (2013.01); G01N 2800/52 (2013.01); G01N 33/6866 (2013.01); G01N 33/6869 (2013.01); G01N 33/6896 (2013.01);
Abstract

A method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of determining whether the human subject is a glatiramer acetate responder by evaluating a biomarker selected from the group consisting of IL-17 concentration, TNF-α concentration, IL-2 concentration and IFN-γ concentration, or a combination thereof, in the blood of the human subject and administering the pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier to the human subject only if the human subject is identified as a glatiramer acetate responder.


Find Patent Forward Citations

Loading…